Multi-target small molecule

This page covers all Multi-target small molecule drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

• ALZT-OP1a · AZTherapies, Inc. · Neurology
  ALZT-OP1a is a small molecule that modulates tau pathology and neuroinflammation to slow cognitive decline in Alzheimer's disease.

Patent intelligence

• multi target small molecule patent landscape — aggregated cliff calendar, attackable patents, originator estates